Člen európskej siete
Euro-Bioimaging
Your text will be added here upon delivery. We have used this placeholder text to give you an idea of how the content will appear on your website. Once provided, the placeholder text will be replaced with your actual content. If needed, we can also assist you with content creation for your website. Feel free to contact us if you are interested.
Projekty
Konzorcium pokročilých proteínových biotechnológií: Model pre podporu ekonomického rastu a zmiernenie úniku mozgov na východnom Slovensku
Kód projektu: 09-I02-03-V01-00021
Akronym/Acronym: APBC
Konzorcium pokročilých proteínových biotechnológií (APBC) je projekt zameraný na medzinárodný model spolupráce v oblasti výskumu a vývoja s vynikajúcimi akademickými partnermi s cieľom riešiť ekonomické a sociálne výzvy na Slovensku a zároveň účinne zmierniť únik mozgov z východného Slovenska. Projekt APBC je strategicky navrhnutý tak, aby podporoval trvalo udržateľný rozvoj využívaním potenciálu proteínovej biotechnológie, vytváraním podmienok pre tvorbu intelektuálneho vlastníctva v danej oblasti a podmienok na dlhodobé prilákanie zariadení na bioprodukciu. Zameraním sa na túto špičkovú oblasť chce konzorcium stimulovať ekonomický rast, vytvárať vysokokvalifikované pracovné príležitosti a zvyšovať celkovú konkurencieschopnosť Slovenska v biotechnologickom segmente. APBC ponúka vzorový koncept overenia princípov na riešenie významných výziev na Slovensku a očakávame, že naša iniciatíva bude motivovať aj ďalšie priemyselné segmenty.
Principal investigator: prof. RNDr. Erik Sedlák, DrSc.
Exploring the structural properties and therapeutic potential of the Hsp70 chaperone’s substrate-binding domain for the treatment of amyloidosis
Project code: 09I03-03-V04-00116
Amyloidosis is a group of diseases characterized by the improper folding and aggregation of light chain, leading to their deposition in various tissues. This impairs their functionality and results in serious health complications. Despite the severity of amyloidosis, there is currently no effective treatment aimed at suppressing light chain aggregation. In this project, we plan to elucidate the structural properties and therapeutic potential of the substrate-binding domain of the chaperone Hsp70 as a novel strategy to combat amyloidosis. To achieve this, we will employ a combination of molecular biology, biophysics, and structural biology techniques. The added value of the project lies in the establishment of protein crystallography as a new scientific discipline at UPJS, both at practical and theoretical levels.
Principal Investigator: RNDr. Michal Nemergut, PhD.
Period: 07/2024 – 06/2026
Breast cancer organoid on a chip for fluorescence lifetime imaging of autophagy and apoptosis induced by targeted treatment with designed ankyrin repeat protein
Project code: 09I03-03-V04-00007
Fluorescence lifetime is a unique parameter of a molecule that is very sensitive to the environment. Therefore, fluorescence lifetime imaging allows identification of local changes in cells with high spatial and temporal resolution. Replacing animal models for human disease is a high priority in our research. This project aims to create a breast cancer organoid composed of cells with various expression of human epidermal growth factor receptor 2 to monitor subcellular and cellular interactions during targeted treatment. The organoid thus exhibits a high degree of heterogeneity and bridges the gap between cell cultures and in vivo models of cancer. The innovative approach of a hydrogel scaffold of recombinant spider silk proteins is proposed to grow cells on a chip. The cells on the chip are targeted by a nano-delivery system consisting of metal-based nanoparticles and a designed ankyrin repeat protein. The composition of the nanoparticles enables multimodal bioimaging and treatment.
Principal Investigator: RNDr. Veronika Huntošová, PhD.
Period: 07/2024 – 06/2026
Rational design of stable and catalytically effective haloalkane dehalogenase DhaA
Project code: 09I03-03-V04-00112
Haloalkane dehalogenases (HLDs) are known as microbial enzymes that can degrade synthetic halogenated compounds that are recognized as pollutants. Three archetypal enzymes (DhlA, DhaA, and LinB) have been extensively studied and modified by protein engineering. However, obtaining biotechnology-required qualitative traits of HLDs still represents a significant obstacle for researchers. This project brings original solution for possible enhancement of stability and catalytic activity of a group of haloalkane dehalogenases. The major achievement will be establishment of methodology for effective improvement of HLD by combination of methods of the rational design and protein evolution. To demonstrate efficiency of the proposed approach, well-characterized haloalkane dehalogenase DhaA will be chosen as a HLD representative.
Principal investigator: RNDr. Ivana Timková, PhD.
Period: 9/2024-6/2026
Naši Partneri
